~~<i id='D9046B738C'><strike id='D9046B738C'><tt id='D9046B738C'><pre id='D9046B738C'></pre></tt></strike></i>~~

Home» explore» explore

explore

author：focus 2025-09-30 10:48:36 Page View：38

HHS 2020 — PhRMA is suing the Biden administration over its new Medicare drug price negotiation program. Graeme Sloan/Sipa USA

WASHINGTON — After losing the drug pricing fight on Capitol Hill, PhRMA is taking its battle to the courts.

The pharmaceutical industry’s biggest lobbying group on Wednesday filed a long-expected lawsuit challenging Democrats’ drug pricing law that allowed Medicare to start negotiating prices for certain medicines.

PhRMA joins a growing club of companies and trades challenging the law. Merck, Bristol Myers Squibb, and the Chamber of Commerce have already filed similar suits in different courts.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Vertigo drug brings hope for rare neuron disorder, Niemann
Next article： Hollywood unions extend contract negotiations for actors

knowledge

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

Commercial surrogacy can be ethical, despite pope’s claims

AdobeOverthepastfewyears,IhavewatchedawonderfulyoungboyI’llcallChadgrowupsmartandfulloflife.Hisparen

Peter Hotez and the public health issue of online harassment

AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

ARCH Venture Partners is raising $3 billion for a life sciences fund

AdobeARCHVenturePartners,oneofthetopinvestorsinthebiotechecosystem,israising$3billionforanewfund.The

WSS

explore

explore

comprehensive

knowledge

ARCH Venture Partners is raising $3 billion for a life sciences fund